Display options
Cite
Gabriel D, Shafry DD, Gordon LB, et al. Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts. Oncotarget. 2017;8(39):64809-64826doi: 10.18632/oncotarget.19363.
Gabriel, D., Shafry, D. D., Gordon, L. B., & Djabali, K. (2017). Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts. Oncotarget, 8(39), 64809-64826. https://doi.org/10.18632/oncotarget.19363
Gabriel, Diana, et al. "Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts." Oncotarget vol. 8,39 (2017): 64809-64826. doi: https://doi.org/10.18632/oncotarget.19363
Gabriel D, Shafry DD, Gordon LB, Djabali K. Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts. Oncotarget. 2017 Jul 18;8(39):64809-64826. doi: 10.18632/oncotarget.19363. eCollection 2017 Sep 12. PMID: 29029393; PMCID: PMC5630293.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Jul 18;8(39):64809-64826. doi: 10.18632/oncotarget.19363. eCollection 2017 Sep 12.

Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts.

Oncotarget

Diana Gabriel, Dinah Dorith Shafry, Leslie B Gordon, Karima Djabali

Affiliations

  1. Department of Dermatology, Epigenetics of Aging, TUM School of Medicine, Technische Universität München, Garching-Munich, Germany.
  2. Department of Pediatrics, Alpert Medical School of Brown University and Hasbro Children's Hospital, Providence, RI, USA.
  3. Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

PMID: 29029393 PMCID: PMC5630293 DOI: 10.18632/oncotarget.19363

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic condition associated with mutations in the

Keywords: Gerotarget; Ionafarnib; autophagy; lamin; progerin; sulforaphane

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflict of interest.

References

  1. J Cell Sci. 2006 Nov 15;119(Pt 22):4644-9 - PubMed
  2. J Cell Biol. 2012 Oct 1;199(1):9-13 - PubMed
  3. Science. 2003 Jun 27;300(5628):2055 - PubMed
  4. Autophagy. 2009 Jan;5(1):129-31 - PubMed
  5. Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8963-8 - PubMed
  6. Cell Mol Life Sci. 2007 May;64(9):1105-27 - PubMed
  7. Annu Rev Biochem. 1998;67:265-306 - PubMed
  8. Nature. 2003 May 15;423(6937):293-8 - PubMed
  9. Circulation. 2014 Jul 1;130(1):27-34 - PubMed
  10. Cell. 2014 Jan 30;156(3):400-7 - PubMed
  11. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4997-5002 - PubMed
  12. BMC Cell Biol. 2005 Jun 27;6:27 - PubMed
  13. Cancer Biol Ther. 2008 Oct;7(10 ):1679-84 - PubMed
  14. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12879-84 - PubMed
  15. Mech Ageing Dev. 2010 Jan;131(1):2-8 - PubMed
  16. Genes Dev. 2011 Dec 15;25(24):2579-93 - PubMed
  17. Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15902-7 - PubMed
  18. J Pathol. 2010 May;221(1):3-12 - PubMed
  19. Biochim Biophys Acta. 2013 Dec;1833(12 ):3448-3459 - PubMed
  20. J Biol Chem. 2005 Sep 2;280(35):31101-8 - PubMed
  21. Hum Mol Genet. 2005 Oct 15;14(20):2959-69 - PubMed
  22. Nutr Rev. 2013 Nov;71(11):709-26 - PubMed
  23. Nat Rev Genet. 2006 Dec;7(12):940-52 - PubMed
  24. FASEB J. 2008 Feb;22(2):603-11 - PubMed
  25. PLoS One. 2010 May 28;5(5):e10874 - PubMed
  26. Aging Cell. 2015 Feb;14 (1):78-91 - PubMed
  27. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2154-9 - PubMed
  28. Int J Cell Biol. 2014;2014:502676 - PubMed
  29. Nat Rev Mol Cell Biol. 2009 Sep;10(9):623-35 - PubMed
  30. J Neurotrauma. 2012 Mar 20;29(5):936-45 - PubMed
  31. J Biol Chem. 2010 Nov 12;285(46):35528-36 - PubMed
  32. Environ Mol Mutagen. 2004;43(1):36-44 - PubMed
  33. Bone Marrow Res. 2011;2011:362938 - PubMed
  34. Sci Transl Med. 2013 Feb 6;5(171):171ps3 - PubMed
  35. Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):36-9 - PubMed
  36. PLoS One. 2007 Dec 05;2(12):e1269 - PubMed
  37. Proc Natl Acad Sci U S A. 2012 Oct 9;109 (41):16666-71 - PubMed
  38. J Cell Sci. 1994 Aug;107 ( Pt 8):2215-8 - PubMed
  39. J Biol Chem. 2006 Dec 29;281(52):39741-5 - PubMed
  40. Nucleus. 2013 Mar-Apr;4(2):142-50 - PubMed
  41. PLoS One. 2013 Jul 24;8(7):e69169 - PubMed
  42. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4949-54 - PubMed
  43. Hum Mol Genet. 2010 Jul 1;19(13):2682-94 - PubMed
  44. Circulation. 2016 Jul 12;134(2):114-25 - PubMed
  45. Aging (Albany NY). 2009 Jan;1(1):28-37 - PubMed
  46. Biotechnol Adv. 2014 Nov 1;32(6):1133-44 - PubMed
  47. J Biol Chem. 1990 Nov 15;265(32):19937-41 - PubMed

Publication Types